This “adiponectin paradox” highlights a complex phenomenon, suggesting that under certain conditions, such as those present in the MS environment, adiponectin may promote inflammatory immune responses instead of exerting its usual anti-inflammatory effects. This evidence concerns the gene ADIPOQ and myeloid sarcoma.